Direkt zum Inhalt
Merck

H8909

Sigma-Aldrich

HBcAg core human

~1 mg/mL, ≥95% (SDS-PAGE), recombinant, expressed in E. coli

Synonym(e):

Hepatitis B virus core antigen

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise

Größe auswählen

100 μG
CHF 457.00

CHF 457.00


Check Cart for Availability


Größe auswählen

Ansicht ändern
100 μG
CHF 457.00

About This Item

MDL-Nummer:
UNSPSC-Code:
12352202
NACRES:
NA.32

CHF 457.00


Check Cart for Availability

Rekombinant

expressed in E. coli

Qualitätsniveau

Assay

≥95% (SDS-PAGE)

Mol-Gew.

18 kDa

Konzentration

~1 mg/mL

UniProt-Hinterlegungsnummer

Lagertemp.

−20°C

Angaben zum Gen

hepatitis B virus ... HBVgp4(944568)
human ... HBVgp4(944568)

Allgemeine Beschreibung

amino acids 1-183 of HBV core antigen.

Biochem./physiol. Wirkung

HBcAg core human is a capsid protein of hepatitis B virus (HBV). It acts as a viral factor for HBV clearance. HBcAg is implicated in viral replication.[1]
Hepatitis B virus core antigen (HBcAg) is a positive control for human HBV antibodies.In humans with chronic HBV (hepatitis B virus) infection, cytotoxic effects of blood T lymphocytes can be suppressed by incubating cells with antibodies against hepatitis B core antigen (HBcAg).[2] The antigen can also work as a T-cell independent antigen in athymic mice. However, it is an efficient immunogen, resulting in T-cell activation and increased anti-HBc levels.[3] High cytoplasmic/membranous expression of HBcAg is associated with increased liver inflammation.[4]

Physikalische Form

Solution in 50% glycerol, 7.5 mM phosphate buffer, pH 7.2, 75 mM NaCl.

Lagerklassenschlüssel

10 - Combustible liquids

WGK

WGK 1

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Long Liu et al.
Journal of medical virology (2020-02-23)
Hepatitis B virus (HBV) chronically infects approximately 350 million people worldwide, and 600 000 deaths are caused by HBV-related hepatic failure. Golgi protein 73 (GP73) is a serum biomarker for liver diseases, including chronic hepatitis B. Here, we determine the effect
J B Kurtz et al.
Journal of virological methods, 96(2), 127-132 (2001-07-11)
A measurable serological response to hepatitis C infection is delayed on average until 70 days after infection. In addition, it may not occur in some immunocompromised people. Detection of free hepatitis C (HCV) core antigen in blood has enabled diagnosis
D R Milich et al.
Journal of immunology (Baltimore, Md. : 1950), 139(4), 1223-1231 (1987-08-15)
Hepatitis B virus nucleocapsid particles (HBcAg) can function as a T cell-independent antigen when injected into athymic mice. However, immunization of euthymic mice with HBcAg results in dramatically increased anti-HBc titers. Therefore we have examined the murine T cell response
C M Chu et al.
Gastroenterology, 92(1), 220-225 (1987-01-01)
The intrahepatic distribution of hepatitis B core antigen (HBcAg) and surface antigen (HBsAg) was studied in 32 patients with chronic type B hepatitis, and the results were correlated with the status of hepatitis B e antigen/antibody (HBeAg/anti-HBe) and with the
Hepatitis B virus nucleocapsid but not free core antigen controls viral clearance in mice
Lin YJ, et al.
Journal of Virology, 86(17), 9266-9273 (2012)

Questions

Reviews

No rating value

Active Filters

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.